Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Prostatic Neoplasms 13 Neoplasms 8 Head and Neck Neoplasms 8 Ovarian Neoplasms 7 Oropharyngeal Neoplasms 5 Lung Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Sarcoma 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Endometrial Neoplasms 3 Depression 3 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Psychological Well-Being 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Motor Activity 2 Melanoma 2 Kidney Neoplasms 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Communication 2

Interventions

tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 epalrestat 1 donafenib 1 Tirzepatide 1 Surveys and Questionnaires 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus × Surveys and Questionnaires × 90 days × Clear all

NCT07061652 2026-04-09

enCompass

UNC Lineberger Comprehensive Cancer Center

Phase NA Recruiting

Diabetes Mellitus, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡